Human binding molecules capable of binding to and neutralizing hepatitis B viruses and uses thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 6, 2016
Grant Date -
Aug 20, 2015
app pub date -
Sep 24, 2013
filing date -
Sep 27, 2012
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The disclosure relates to binding molecules, such as human monoclonal antibodies, that bind to Hepatitis B viruses, and have a broad neutralizing activity against such Hepatitis B viruses. The disclosure further provides nucleic acid molecules encoding the binding molecules, and compositions comprising the binding molecules. The binding molecules can be used in the diagnosis, prophylaxis and/or treatment of Hepatitis B.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully